Published in Ann Surg on October 01, 2004
Pig pancreas anatomy: implications for pancreas procurement, preservation, and islet isolation. Transplantation (2008) 1.27
Prediction of marginal mass required for successful islet transplantation. J Invest Surg (2010) 1.23
Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms. Diabetes (2013) 1.17
Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation. Endocr Rev (2008) 1.12
Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. Endocr Rev (2011) 1.10
Surgical aspects of human islet isolation. Islets (2010) 1.03
Redox modulation protects islets from transplant-related injury. Diabetes (2010) 0.98
HLA sensitization in islet transplantation. Clin Transpl (2006) 0.97
Quadrupole magnetic sorting of porcine islets of Langerhans. Tissue Eng Part C Methods (2009) 0.92
Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients. J Clin Endocrinol Metab (2008) 0.90
Islet cell transplantation. Postgrad Med J (2007) 0.88
Recovery of endocrine function after islet and pancreas transplantation. Curr Diab Rep (2012) 0.85
Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics. J Diabetes Sci Technol (2008) 0.82
Biomolecular surface engineering of pancreatic islets with thrombomodulin. Acta Biomater (2010) 0.81
Islet cell xenotransplantation: a serious look toward the clinic. Xenotransplantation (2014) 0.78
Transplantation for type 1 diabetes mellitus. Whole organ or islets? Hippokratia (2009) 0.78
Islet cell transplantation. Semin Intervent Radiol (2006) 0.75
Stem Cells in the Treatment of Insulin-Dependent Diabetes Mellitus. Acta Naturae (2016) 0.75
Pancreas Islet Transplantation for Patients With Type 1 Diabetes Mellitus: A Clinical Evidence Review. Ont Health Technol Assess Ser (2015) 0.75
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med (2000) 18.26
Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med (1998) 4.30
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA (2003) 3.33
Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant (2004) 2.55
Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes (2001) 2.51
Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery (1967) 2.49
Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes (2002) 2.36
Edmonton's islet success tough to duplicate elsewhere. Lancet (2003) 2.18
Automated islet isolation from human pancreas. Diabetes (1989) 2.13
Transplantation of intact pancreatic islets in rats. Surgery (1972) 2.05
Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Transplantation (1991) 1.98
Improved human islet isolation using a new enzyme blend, liberase. Diabetes (1997) 1.84
Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg (2003) 1.67
Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med (1988) 1.65
A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation (1995) 1.53
Edmonton's islet success has indeed been replicated elsewhere. Lancet (2003) 1.45
The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med (1989) 1.35
Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation (2003) 1.32
Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? Diabetes (2003) 1.27
Human islet transplantation: a preliminary report. Transplant Proc (1977) 1.18
Transplantation of isolated pancreatic islets across strong and weak histocompatibility barriers. Transplant Proc (1973) 1.16
Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? Ann Surg (2000) 1.16
Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg (2000) 1.14
Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver. Diabetes (2004) 1.13
Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1992) 1.06
The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation (2003) 1.03
Progressive deterioration of endocrine function after intraportal but not kidney subcapsular rat islet transplantation. Diabetes (1991) 0.97
Pancreas transplant outcomes for United States (US) cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) as of October, 2000. Clin Transpl (2000) 0.91
Sequential kidney/islet transplantation using prednisone-free immunosuppression. Am J Transplant (2002) 0.89
Successful [correction of Succesful] transplantation of human islets in recipients bearing a kidney graft. Diabetologia (2002) 0.86
Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest (2005) 4.26
Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med (2003) 4.12
Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J Clin Invest (2013) 2.38
Comprehensive identification of protein substrates of the Dot/Icm type IV transporter of Legionella pneumophila. PLoS One (2011) 2.37
Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl (2012) 2.32
Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med (2002) 2.29
Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes (2004) 2.22
Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation (2004) 2.13
Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Ann Surg (2015) 2.00
Survival following liver transplantation from non-heart-beating donors. Ann Surg (2004) 1.96
Elevated mouse hepatic betatrophin expression does not increase human β-cell replication in the transplant setting. Diabetes (2013) 1.90
Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl (2005) 1.87
Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab (2006) 1.76
Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl (2006) 1.72
Geographic inequity in access to livers for transplantation. Transplantation (2011) 1.71
Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg (2003) 1.67
Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes (2003) 1.55
B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat Med (2007) 1.53
Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol (2006) 1.51
Genome-wide analysis of histone modifications in human pancreatic islets. Genome Res (2010) 1.51
Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies. Clin Transplant (2006) 1.50
GITR Blockade Facilitates Treg Mediated Allograft Survival. Transplantation (2009) 1.48
Mucosal IL-8 and TGF-beta recruit blood monocytes: evidence for cross-talk between the lamina propria stroma and myeloid cells. J Leukoc Biol (2006) 1.47
Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol (2007) 1.47
Decreased use of iliac extensions and reduced graft junctions with software-assisted centerline measurements in selection of endograft components for endovascular aneurysm repair. J Vasc Surg (2004) 1.46
Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transpl (2007) 1.46
Geographic differences in access to transplantation in the United States. Transplantation (2003) 1.42
Immune rejection after pancreatic islet cell transplantation: in vivo dual contrast-enhanced MR imaging in a mouse model. Radiology (2012) 1.41
Discovery of a human peptide sequence signaling islet neogenesis. Endocr Pract (2008) 1.38
Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol (2004) 1.34
B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol (2006) 1.34
Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation (2003) 1.32
{beta}-Cell function following human islet transplantation for type 1 diabetes. Diabetes (2005) 1.28
Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? Diabetes (2003) 1.27
Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. J Biol Chem (2002) 1.25
Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes (2003) 1.25
Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg (2002) 1.22
Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant (2004) 1.20
Minimizing morbidity of organ donation: analysis of factors for perioperative complications after living-donor nephrectomy in the United States. Transplantation (2008) 1.20
Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells. Elife (2013) 1.19
Global expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays. Clin Cancer Res (2003) 1.18
A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice. Diabetes (2010) 1.18
Research resource: the pdx1 cistrome of pancreatic islets. Mol Endocrinol (2012) 1.17
Glucose regulation of insulin gene transcription and pre-mRNA processing in human islets. Diabetes (2007) 1.17
Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes. Diabetes (2005) 1.16
TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. Eur J Immunol (2014) 1.15
Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol. Diabetes (2013) 1.15
RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes. J Exp Med (2008) 1.14
In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice. J Immunol (2008) 1.14
Overexpression of hepatocyte nuclear factor-4α initiates cell cycle entry, but is not sufficient to promote β-cell expansion in human islets. Mol Endocrinol (2012) 1.13
Cx36 makes channels coupling human pancreatic beta-cells, and correlates with insulin expression. Hum Mol Genet (2008) 1.12
Calcineurin signaling regulates human islet {beta}-cell survival. J Biol Chem (2010) 1.09
Collaborative coping and daily mood in couples dealing with prostate cancer. Psychol Aging (2008) 1.09
The involvement of FcR mechanisms in antibody-mediated rejection. Transplantation (2007) 1.08
MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic β-cells. Diabetes (2012) 1.08